Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.19.3
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Sep. 30, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 2,091 $ 8,044
Restricted cash 312 312
Accounts receivable, less allowance of $2,084 and $850 in 2019 and 2018, respectively 8,474 11,112
Inventory 11,537 12,248
Prepaid expenses and other current assets 875 1,591
Total current assets 23,289 33,307
Property, plant, and equipment, net 1,340 1,975
Goodwill 2,926 2,926
Other assets 718 308
Total assets 28,273 38,516
Current liabilities:    
Accounts payable 6,604 5,953
Accrued liabilities 4,950 7,538
Deferred revenue, current portion 2,512 2,476
Total current liabilities 14,066 15,967
Deferred income taxes, net 71 77
Warranty accrual 701 447
Other liabilities 1,145 100
Term loan 13,356 10,836
Total liabilities 29,339 27,427
Commitments and contingencies — Note 11
Stockholders' (deficit) equity:    
Preferred stock, par value $0.001 per share; 1,000 shares authorized; 0 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively
Common stock, par value $0.001 per share; 40,000 shares authorized, 21,954 and 21,072 shares issued and outstanding as of September 30, 2019 and December 31, 2018, respectively 22 21
Additional paid-in-capital 230,712 228,430
Accumulated other comprehensive loss (840) (670)
Accumulated deficit (230,960) (216,692)
Total stockholders' (deficit) equity (1,066) 11,089
Total liabilities and stockholders' (deficit) equity $ 28,273 $ 38,516